Calcium-dependent inactivation controls cardiac L-type Ca2+ currents under β-adrenergic stimulation

J Gen Physiol. 2019 Jun 3;151(6):786-797. doi: 10.1085/jgp.201812236. Epub 2019 Feb 27.

Abstract

The activity of L-type calcium channels is associated with the duration of the plateau phase of the cardiac action potential (AP) and it is controlled by voltage- and calcium-dependent inactivation (VDI and CDI, respectively). During β-adrenergic stimulation, an increase in the L-type current and parallel changes in VDI and CDI are observed during square pulses stimulation; however, how these modifications impact calcium currents during an AP remains controversial. Here, we examined the role of both inactivation processes on the L-type calcium current activity in newborn rat cardiomyocytes in control conditions and after stimulation with the β-adrenergic agonist isoproterenol. Our approach combines a self-AP clamp (sAP-Clamp) with the independent inhibition of VDI or CDI (by overexpressing CaVβ2a or calmodulin mutants, respectively) to directly record the L-type calcium current during the cardiac AP. We find that at room temperature (20-23°C) and in the absence of β-adrenergic stimulation, the L-type current recapitulates the AP kinetics. Furthermore, under our experimental setting, the activity of the sodium-calcium exchanger (NCX) does not affect the shape of the AP. We find that hindering either VDI or CDI prolongs the L-type current and the AP in parallel, suggesting that both inactivation processes modulate the L-type current during the AP. In the presence of isoproterenol, wild-type and VDI-inhibited cardiomyocytes display mismatched L-type calcium current with respect to their AP. In contrast, CDI-impaired cells maintain L-type current with kinetics similar to its AP, demonstrating that calcium-dependent inactivation governs L-type current kinetics during β-adrenergic stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects*
  • Action Potentials / physiology*
  • Adrenergic beta-Agonists / pharmacology*
  • Animals
  • Calcium / metabolism*
  • Calcium Channels, L-Type / metabolism*
  • Heart / drug effects*
  • Ion Transport / drug effects
  • Ion Transport / physiology
  • Isoproterenol / pharmacology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Sodium-Calcium Exchanger / metabolism

Substances

  • Adrenergic beta-Agonists
  • Calcium Channels, L-Type
  • Sodium-Calcium Exchanger
  • Isoproterenol
  • Calcium